BCL2 and cancer: Cancer progression per se is not only dependent on uncontrolled tumor cell proliferation, but also on reduced susceptibility of the malignant cells to apoptosis, which is deregulated by various mechanisms including upregulation of anti-apoptotic proteins like BCL-2 [11,46].